Publicaciones (282) Publicaciones de MARÍA LUISA NAVARRO GÓMEZ

2024

  1. Follow-up for 3 years of a pediatric population diagnosed in 2018 with mother-to-child transmission of HIV in 8 Latin American countries in the PLANTAIDS cohort

    BMC Infectious Diseases, Vol. 24, Núm. 1

  2. Host gene expression signatures to identify infection type and organ dysfunction in children evaluated for sepsis: a multicentre cohort study

    The Lancet Child and Adolescent Health, Vol. 8, Núm. 5, pp. 325-338

  3. Immunogenicity of the Conjugate Meningococcal ACWY-TT Vaccine in Children and Adolescents Living with HIV

    Microorganisms, Vol. 12, Núm. 1

  4. The Association of HIV-1 Neutralization in Aviremic Children and Adults with Time to ART Initiation and CD4+/CD8+ Ratios

    Vaccines, Vol. 12, Núm. 1

  5. Transmitted Drug Resistance and HIV Diversity Among Adolescents Newly Diagnosed With HIV in Spain

    Pediatric Infectious Disease Journal, Vol. 43, Núm. 1, pp. 40-48

2023

  1. Antibody levels to SARS-CoV-2 spike protein in mothers and children from delivery to six months later

    Birth, Vol. 50, Núm. 2, pp. 418-427

  2. Drug resistance in children and adolescents with HIV in Panama

    Journal of Antimicrobial Chemotherapy, Vol. 78, Núm. 2, pp. 423-435

  3. IgG antibody levels against the SARS-CoV-2 spike protein in mother–child dyads after COVID-19 vaccination

    Infection

  4. Immunisation schedule of the Spanish Association of Paediatrics: 2023 Recommendations

    Anales de Pediatria, Vol. 98, Núm. 1, pp. 58.e1-58.e10

  5. Increased risk of group B streptococcal sepsis and meningitis in HIV-exposed uninfected infants in a high-income country

    European Journal of Pediatrics, Vol. 182, Núm. 2, pp. 575-579

  6. Invasive Bacterial Infections in Children With Sickle Cell Disease: 2014–2019

    Pediatrics, Vol. 152, Núm. 4

  7. Long-term evolution in liver disease markers and immune and lipid profiles in vertically HIV/HCV-coinfected youths with sustained viral response after direct-acting antivirals therapy

    Biomedicine and Pharmacotherapy, Vol. 162

  8. Nucleoside/nucleotide reverse transcriptase inhibitor sparing regimen with once daily integrase inhibitor plus boosted darunavir is non-inferior to standard of care in virologically-suppressed children and adolescents living with HIV – Week 48 results of the randomised SMILE Penta-17-ANRS 152 clinical trial

    eClinicalMedicine, Vol. 60

  9. Serologic evolution and follow-up to IgG antibodies of infants born to mothers with gestational COVID

    BMC Pregnancy and Childbirth, Vol. 23, Núm. 1

  10. The hidden side of infective endocarditis: Diagnostic and management of 500 consecutive cases in noncardiac surgery centers (2009–2018)

    Surgery (United States), Vol. 174, Núm. 3, pp. 602-610

  11. The need for evolution in the management of febrile neutropenia in pediatric cancer: TRIIO KIDS update

    Clinical and Translational Oncology, Vol. 25, Núm. 3, pp. 633-642

  12. Transient Viral Rebound in Children with Perinatally Acquired HIV-1 Induces a Unique Soluble Immunometabolic Signature Associated with Decreased CD4/CD8 Ratio

    Journal of the Pediatric Infectious Diseases Society, Vol. 12, Núm. 3, pp. 143-151

  13. Use of Monoclonal Antibodies in a Pediatric Patient With Severe Combined Immunodeficiency and Persistent SARS-CoV-2 Infection

    The Pediatric infectious disease journal, Vol. 42, Núm. 8, pp. e290-e292

2022

  1. Children living with HIV in Europe: do migrants have worse treatment outcomes?

    HIV Medicine, Vol. 23, Núm. 2, pp. 186-196

  2. Clinical spectrum of COVID-19 and risk factors associated with severity in Spanish children

    European journal of pediatrics, Vol. 181, Núm. 3, pp. 1105-1115